Home Research-feed Channel Rankings GCT THU AI TR Open Data Must Reading

views: 2

Ravi Guthikonda

Department of Medicinal Chemistry, Merck Research Laboratories Rahway, NJ 07065, USA

Sign in to view more

Show Academic Trajectory

Ego Network

D-Core

Research Interests

Author Statistics

Experience

Education

Bio

None

Papers3 papers

Sort

By YearBy Citation

Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists

Helen E. Armstrong,Amy Galka,Linus S. Lin,Thomas J. Lanza,James P. Jewell,Shrenik K. Shah,Ravi Guthikonda,Quang Truong,Linda L. Chang,Grace Quaker,Vincent J. Colandrea,Xinchun Tong

Bioorganic & Medicinal Chemistry Letters, no. 8 (2007): 2184-2187

Cited by22EIWOSBibtex

Substituted 2-aminopyridines as inhibitors of nitric oxide synthases

William K Hagmann,Charles G Caldwell,Ping Chen,Philippe L Durette,Craig K Esser,Thomas J Lanza,Ihor E Kopka,Ravi Guthikonda,Shrenik K Shah,Malcolm MacCoss,Renee M Chabin,Daniel Fletcher

Bioorganic & Medicinal Chemistry Letters, no. 17 (2000): 1975-1978

EIWOSBibtex

Cyclopentyl modulators of chemokine receptor activity

Paul E Finke,Kerry A Hilfiker,Malcolm Maccoss,Kevin T Chapman,Jennifer L Loebach,Sander G Mills,Ravi Guthikonda,Shrenik K Shah, D Kim,Dongming Shen,Bryan Oates

(2000)

Cited by60Bibtex

View All

Base Info Papers Patents Projects